114 related articles for article (PubMed ID: 10536198)
1. Memantine does not substantially affect brain stimulation reward: comparison with MK-801.
Tzschentke TM; Schmidt WJ
Brain Res; 1999 Oct; 845(2):192-8. PubMed ID: 10536198
[TBL] [Abstract][Full Text] [Related]
2. Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.
Tzchentke TM; Schmidt WJ
Psychopharmacology (Berl); 2000 Apr; 149(3):225-34. PubMed ID: 10823402
[TBL] [Abstract][Full Text] [Related]
3. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
4. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.
Carlezon WA; Wise RA
Brain Res; 1993 Aug; 620(2):339-42. PubMed ID: 8369967
[TBL] [Abstract][Full Text] [Related]
5. Facilitation of brain stimulation reward by MK-801 (dizocilpine) may be independent of D2-like dopamine receptor stimulation in rats.
Clements RL; Greenshaw AJ
Psychopharmacology (Berl); 2005 Oct; 182(1):65-74. PubMed ID: 16133130
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
Olds ME
Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
[TBL] [Abstract][Full Text] [Related]
7. Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.
Hillhouse TM; Porter JH; Negus SS
Psychopharmacology (Berl); 2014 Jul; 231(13):2705-16. PubMed ID: 24522331
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ inhibits the association of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels.
Fujimoto M; Iida H; Homma T; Kimura I; Mori M; Hamana H
Biol Pharm Bull; 2008 Sep; 31(9):1813-5. PubMed ID: 18758084
[TBL] [Abstract][Full Text] [Related]
10. Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat.
Görgülü A; Kinş T; Cobanoglu S; Unal F; Izgi NI; Yanik B; Küçük M
Acta Neurochir (Wien); 2000; 142(11):1287-92. PubMed ID: 11201645
[TBL] [Abstract][Full Text] [Related]
11. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
Frankiewicz T; Potier B; Bashir ZI; Collingridge GL; Parsons CG
Br J Pharmacol; 1996 Feb; 117(4):689-97. PubMed ID: 8646415
[TBL] [Abstract][Full Text] [Related]
12. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
13. MK-801 and memantine act differently on short-term memory tested with different time-intervals in the Morris water maze test.
Duda W; Wesierska M; Ostaszewski P; Vales K; Nekovarova T; Stuchlik A
Behav Brain Res; 2016 Sep; 311():15-23. PubMed ID: 27180167
[TBL] [Abstract][Full Text] [Related]
14. Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats.
Sukhanov IM; Zakharova ES; Danysz W; Bespalov AY
Behav Pharmacol; 2004 Jul; 15(4):263-71. PubMed ID: 15252276
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
[TBL] [Abstract][Full Text] [Related]
16. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Zakharova ES; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
[TBL] [Abstract][Full Text] [Related]
17. Infusion of (+) -MK-801 and memantine -- contrasting effects on radial maze learning in rats with entorhinal cortex lesion.
Zajaczkowski W; Quack G; Danysz W
Eur J Pharmacol; 1996 Feb; 296(3):239-46. PubMed ID: 8904075
[TBL] [Abstract][Full Text] [Related]
18. MK-801 and memantine inhibit a centrally induced increase in myocardial oxygen demand in rabbits.
Monassier L; Tibiriça E; Roegel JC; Feldman J; Bousquet P
Eur J Pharmacol; 1996 Jun; 305(1-3):109-13. PubMed ID: 8813539
[TBL] [Abstract][Full Text] [Related]
19. The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones.
Jones MW; McClean M; Parsons CG; Headley PM
Neuropharmacology; 2001 Jul; 41(1):50-61. PubMed ID: 11445185
[TBL] [Abstract][Full Text] [Related]
20. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.
Wu YN; Johnson SW
Brain Res; 2015 Apr; 1603():1-7. PubMed ID: 25656790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
